Detalhe da pesquisa
1.
Unveiling Discrepant and Rare Dihydropyrimidine Dehydrogenase (DPYD) Results Using an In-House Genotyping Test: A Case Series.
J Natl Compr Canc Netw
; 22(4)2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754463
2.
Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease-Associated Hemolysis.
Ann Pharmacother
; 57(8): 970-977, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36476151
3.
Use of patient-reported outcome measures for oncology drugs receiving accelerated approval.
Support Care Cancer
; 31(10): 602, 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773545
4.
Tafasitamab and lenalidomide for relapsed/refractory diffuse large B-cell lymphoma in a patient on chronic intermittent hemodialysis.
J Oncol Pharm Pract
; 29(1): 239-241, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35585701
5.
Measuring the Impact of a Pharmacist-Driven Blood Factor Education Program: A Prospective, Single-Center Observational Study.
Hosp Pharm
; 58(3): 282-288, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37216073
6.
Daratumumab for the Treatment of Multiple Myeloma: A Review of Clinical Applicability and Operational Considerations.
Ann Pharmacother
; 56(8): 927-940, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34963325
7.
Eptacog Beta for Bleeding Treatment and Prevention in Congenital Hemophilia A and B With Inhibitors: A Review of Clinical Data and Implications for Clinical Practice.
Ann Pharmacother
; 56(7): 831-838, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595941
8.
Risk factors associated with palbociclib-induced neutropenia in patients with metastatic breast cancer.
Support Care Cancer
; 30(12): 9803-9809, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260177
9.
Impact of obesity on safety outcomes and treatment modifications with ado-trastuzumab emtansine in breast cancer patients.
J Oncol Pharm Pract
; 28(1): 49-54, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33356991
10.
Implementation, utilization, and evaluation of a pharmacist-driven romiplostim dosing service for patients with immune thrombocytopenia at a multisite cancer centre.
J Oncol Pharm Pract
; 28(3): 613-617, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35060795
11.
New and emerging therapies for the treatment of relapsed/refractory diffuse large B-cell lymphoma.
J Oncol Pharm Pract
; 28(8): 1848-1858, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-35469489
12.
Comparative Utilization and Efficacy of Thrombopoietin Receptor Agonists in Relapsed/Refractory Immune Thrombocytopenia.
Am J Ther
; 28(5): e525-e530, 2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33491968
13.
Bruton tyrosine kinase inhibitors for Waldenström macroglobulinemia: A review.
J Oncol Pharm Pract
; 27(8): 1993-1999, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34558376
14.
Evaluation of a pharmacist-driven rapid infusion rituximab conversion protocol at a multisite cancer center.
J Oncol Pharm Pract
; 27(8): 1914-1918, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33297847
15.
Ibrutinib treatment via alternative administration in a patient with chronic lymphocytic leukemia and dysphagia.
J Oncol Pharm Pract
; 27(5): 1265-1269, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33106104
16.
Publication rates of hematology/oncology abstracts presented at major pharmacy association meetings.
J Oncol Pharm Pract
; : 10781552211004700, 2021 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33779372
17.
Retrospective Analysis of Clinical Outcomes Associated With the Use of Pegfilgrastim On-body Injector in Patients Receiving Chemotherapy Requiring Granulocyte Colony-Stimulating Factor Support.
Hosp Pharm
; 56(2): 77-80, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33790481
18.
Mogamulizumab: An Anti-CC Chemokine Receptor 4 Antibody for T-Cell Lymphomas.
Ann Pharmacother
; 54(4): 371-379, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31648540
19.
Vonicog alfa for the management of von Willebrand disease: a comprehensive review and single-center experience.
J Thromb Thrombolysis
; 49(3): 431-440, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31902122
20.
Successful Ferric Carboxymaltose Desensitization in a Patient With Prior Reactions to Intravenous Iron Therapies.
Am J Ther
; 31(2): e205-e206, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433089